2016 SECIM P&F Projects

In 2016, SECIM awarded pilot & feasibility project funds to the following researchers:

  • Dr. Sarah Borengasser, University of Colorado at Denver
    “Targeted Metabolomics for 1C Metabolites from Maternal Dried Blood Spot Samples
    Prior to and During Pregnancy”
  • Dr. Fernando Bril, University of Florida
    “Identification of Biomarkers Associated with the Progression of Nonalcoholic Fatty Liver
  • Dr. Hans Ghayee, University of Florida
    “Metabolic Analysis of Human PCC/PGL Cancer Cells Reveals the Importance of
    Chromogranin-mediated Deacidification in Cancer Survival”
  • Dr. John Hartman, University of Alabama at Birmingham
    “Integration of genetic and metabolic networks that influence cellular aging”
  • Dr. Julie Johnson, University of Florida
    “Investigating Eicosanoids Implications on the Blood Pressure Response to Thiazide Diuretics”
  • Dr. Peter Kanetsky, Moffitt Cancer Center
    “Metabolomics of Cutaneous Malignant Melanoma”
  • Dr. Hendrik Luesch, University of Florida
    “The functional interplay of marine natural products: marine cyanobacterial small molecules
    as activators of secondary metabolism in marine actinobacteria”
  • Dr. Luke Norton, University of Texas Health Science Center at San Antonio
    “The Regulation of Hepatic Pyruvate Metabolism by Pioglitazone”
  • Dr. Christina Pacak, University of Florida
    “Human Urinary Renal Epithelial Cells as Metabolic Biomarkers for Barth Syndrome”
  • Dr. Mohan Raizada, University of Florida
    “Discovery of an Unique Bacterial Metabolic Profile in Resistant Hypertensive Patients”
  • Dr. Stephanie Wohlgemuth, University of Florida
    “Effect of early gestational heat stress on the skeletal muscle metabolome in dairy cows”